Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

SPI 112Me is a prodrug form of the Src homology region 2 domain-containing phosphatase 2 (SHP-2) inhibitor SPI 112 (Item No. 29474).1 It is hydrolyzed by esterases intracellularly to form SPI 112. SPI 112Me inhibits the protein tyrosine phosphatase (PTP) activity of SHP-2 containing a constitutively activating glutamate-to-lysine substitution at position 76 (SHP-2E76K) in TF-1 leukemia cells expressing the mutant enzyme. SPI 112Me (20 µM) inhibits Paxillin dephosphorylation, ERK1/2 activation, and cell migration in EGF-stimulated MDA-MB-468 breast cancer cells.
WARNING This product is not for human or veterinary use.
1. Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-